Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Spatial Genomics and Transcriptomics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
5.2.2. By Product Type (Instruments, Consumables, Software)
5.2.3. By Application (Translational Research v/s Drug discovery & development)
5.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
5.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.6. By Company (2022)
5.3. Market Map
5.3.1 By Technique
5.3.2 By Product Type
5.3.3 By Application
5.3.4 By End User
5.3.5 By Region
6. North America Spatial Genomics and Transcriptomics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
6.2.2. By Product Type (Instruments, Consumables, Software)
6.2.3. By Application (Translational Research v/s Drug discovery & development)
6.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Spatial Genomics and Transcriptomics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Technique
6.3.1.2.2. By Product Type
6.3.1.2.3. By Application
6.3.1.2.4. By End User
6.3.2. Canada Spatial Genomics and Transcriptomics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Technique
6.3.2.2.2. By Product Type
6.3.2.2.3. By Application
6.3.2.2.4. By End User
6.3.3. Mexico Spatial Genomics and Transcriptomics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Technique
6.3.3.2.2. By Product Type
6.3.3.2.3. By Application
6.3.3.2.4. By End User
7. Europe Spatial Genomics and Transcriptomics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
7.2.2. By Product Type (Instruments, Consumables, Software)
7.2.3. By Application (Translational Research v/s Drug discovery & development)
7.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Spatial Genomics and Transcriptomics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technique
7.3.1.2.2. By Product Type
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2. Germany Spatial Genomics and Transcriptomics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technique
7.3.2.2.2. By Product Type
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. United Kingdom Spatial Genomics and Transcriptomics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technique
7.3.3.2.2. By Product Type
7.3.3.2.3. By Application
7.3.3.2.4. By End User
7.3.4. Italy Spatial Genomics and Transcriptomics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Technique
7.3.4.2.2. By Product Type
7.3.4.2.3. By Application
7.3.4.2.4. By End User
7.3.5. Spain Spatial Genomics and Transcriptomics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Technique
7.3.5.2.2. By Product Type
7.3.5.2.3. By Application
7.3.5.2.4. By End User
8. Asia-Pacific Spatial Genomics and Transcriptomics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
8.2.2. By Product Type (Instruments, Consumables, Software)
8.2.3. By Application (Translational Research v/s Drug discovery & development)
8.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Spatial Genomics and Transcriptomics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technique
8.3.1.2.2. By Product Type
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. India Spatial Genomics and Transcriptomics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technique
8.3.2.2.2. By Product Type
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. Japan Spatial Genomics and Transcriptomics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technique
8.3.3.2.2. By Product Type
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4. South Korea Spatial Genomics and Transcriptomics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Technique
8.3.4.2.2. By Product Type
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Australia Spatial Genomics and Transcriptomics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Technique
8.3.5.2.2. By Product Type
8.3.5.2.3. By Application
8.3.5.2.4. By End User
9. South America Spatial Genomics and Transcriptomics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
9.2.2. By Product Type (Instruments, Consumables, Software)
9.2.3. By Application (Translational Research v/s Drug discovery & development)
9.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Spatial Genomics and Transcriptomics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technique
9.3.1.2.2. By Product Type
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. Argentina Spatial Genomics and Transcriptomics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technique
9.3.2.2.2. By Product Type
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. Colombia Spatial Genomics and Transcriptomics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technique
9.3.3.2.2. By Product Type
9.3.3.2.3. By Application
9.3.3.2.4. By End User
10. Middle East and Africa Spatial Genomics and Transcriptomics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
10.2.2. By Product Type (Instruments, Consumables, Software)
10.2.3. By Application (Translational Research v/s Drug discovery & development)
10.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Spatial Genomics and Transcriptomics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Technique
10.3.1.2.2. By Product Type
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Spatial Genomics and Transcriptomics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Technique
10.3.2.2.2. By Product Type
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3. UAE Spatial Genomics and Transcriptomics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Technique
10.3.3.2.2. By Product Type
10.3.3.2.3. By Application
10.3.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.1.1 Growing demand for lab automation activities
11.1.2 Growing adoption of lab informatics by biobanks
11.1.3 Growing introduction of technologically advanced software services
11.2. Challenges
11.2.1 Lack of integration standards for laboratory informatics
11.2.2 Stringent Regulations
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Spatial Genomics and Transcriptomics Market: SWOT Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Business Overview
15.2. Product Offerings
15.3. Recent Developments
15.4. Financials (As Reported)
15.5. Key Personnel
15.6. SWOT Analysis
15.6.1 10X Genomics Inc.
15.6.2 Akoya Bioscience Ltd.
15.6.3 Biospyder Technologies Inc.
15.6.4 BioTechne Corporation.
15.6.5 Dovetail Genomics LLC.
15.6.6 Fluidigm Corporation.
15.6.7 Genomic Vision SA.
15.6.8 Illumina Inc.
15.6.9 Lunaphore Technologies SA.
15.6.10 Nanostring Technolgies Inc.
16. Strategic Recommendations